|
Ozanimod (Zeposia®) |
|
|
|
|
Ozanimod (Zeposia®) |
|
|
|
|
Pabrinex injection |
|
|
|
|
Paclitaxel |
|
|
|
|
Paclitaxel injection |
|
Negative TA
|
|
|
Palbociclib (Ibrance®) |
|
|
|
|
Palforzia® |
|
|
|
|
Palifermin injection |
|
Private patients only
|
|
|
Paliperidone (Byannli®) |
|
6 monthly injection
|
|
|
Paliperidone (Trevicta®) |
|
- Third line option
- Patient has been stable mentally for at least 12 months and had a stable dose of paliperidone palmitate monthly injection and has not required a dosage adjustment in the last six months
- 12 months using the monthly injections and no dose adjustment for the last six months before considering the three-monthly injection
- APC verdict - present status red. Future status amber with a framework in primary care before transfer (commissioning discussion)
|
